1-deoxynojirimycin has been researched along with Dysphagia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Calì, F; Costanzo, MC; Fiumara, A; Musumeci, SA; Nicotera, AG; Vinci, M; Vitello, A | 1 |
Keage, M; Lewis, C; Schubiger, D; Velakoulis, D; Vogel, AP; Walterfang, M; Watanabe, M | 1 |
Farhat, N; King, MC; Machielse, L; Porter, FD; Sinaii, N; Smith, AC; Solomon, BI | 1 |
Barone, R; Di Rocco, M; Fiumara, A; Madeo, A | 1 |
Sedel, F | 1 |
Amitrano, M; Andria, G; Astarita, L; Bruschini, D; Della Casa, R; Fecarotta, S; Parenti, G; Romano, A | 1 |
Chien, YH; Imrie, J; Patterson, MC; Rushton, D; Schubiger, D; Walterfang, M | 1 |
2 review(s) available for 1-deoxynojirimycin and Dysphagia
Article | Year |
---|---|
[Clinical diagnosis of the adult form of Niemann-Pick type C disease].
Topics: 1-Deoxynojirimycin; Adult; Cerebellar Ataxia; Cognition Disorders; Deglutition Disorders; Dysarthria; Enzyme Inhibitors; Epilepsy; Humans; Mental Disorders; Movement Disorders; Niemann-Pick Disease, Type C; Splenomegaly; Supranuclear Palsy, Progressive | 2010 |
Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat.
Topics: 1-Deoxynojirimycin; Animals; Deglutition Disorders; Humans; Niemann-Pick Disease, Type C | 2012 |
5 other study(ies) available for 1-deoxynojirimycin and Dysphagia
Article | Year |
---|---|
Novel compound heterozygous mutation in
Topics: 1-Deoxynojirimycin; Adult; Apathy; Brain; Cognitive Dysfunction; Corpus Callosum; Deglutition Disorders; Female; High-Throughput Nucleotide Sequencing; Humans; Intracellular Signaling Peptides and Proteins; Language Disorders; Magnetic Resonance Imaging; Mutation, Missense; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Vesicular Transport Proteins | 2020 |
Characterization of Dysphagia and Longitudinal Changes in Swallowing Function in Adults with Niemann-Pick Disease Type C Treated with Miglustat.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Deglutition; Deglutition Disorders; Enzyme Inhibitors; Humans; Neurodegenerative Diseases; Niemann-Pick Disease, Type C; Retrospective Studies | 2021 |
Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
Topics: 1-Deoxynojirimycin; Adolescent; Child; Child, Preschool; Cohort Studies; Deglutition; Deglutition Disorders; Enzyme Inhibitors; Female; Humans; Male; Niemann-Pick Disease, Type C; Pneumonia, Aspiration | 2020 |
Miglustat Does Not Prevent Neurological Involvement in Niemann Pick C Disease.
Topics: 1-Deoxynojirimycin; Central Nervous System Agents; Child; Deglutition Disorders; Female; Humans; Male; Motor Activity; Niemann-Pick Disease, Type C; Saccades; Treatment Outcome | 2015 |
The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat.
Topics: 1-Deoxynojirimycin; Child; Deglutition; Deglutition Disorders; Demography; Enzyme Inhibitors; Female; Fluoroscopy; Humans; Infant; Male; Niemann-Pick Disease, Type C; Video Recording | 2011 |